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Zinc is an essential micronutrient, so it is important to eluci-
date the molecular mechanisms of zinc homeostasis, including
the functional properties of zinc transporters. Mammalian zinc
transporters are classified in two major families: the SLC30
(ZnT) family and the SLC39 family. The prevailing view is that
SLC30 family transporters function to reduce cytosolic zinc
concentration, either through efflux across the plasma mem-
brane or through sequestration in intracellular compartments,
and that SLC39 family transporters function in the opposite
direction to increase cytosolic zinc concentration. We demon-
strated that human ZnT5 variant B (ZnT5B (hZTL1)), an iso-
form expressed at the plasma membrane, operates in both the
uptake and the efflux directionswhen expressed inXenopus lae-
vis oocytes. We measured increased activity of the zinc-respon-
sive metallothionein 2a (MT2a) promoter when ZnT5b was co-
expressed with an MT2a promoter-reporter plasmid construct
in human intestinal Caco-2 cells, indicating increased total
intracellular zinc concentration. Increased cytoplasmic zinc
concentration mediated by ZnT5B, in the absence of effects on
intracellular zinc sequestration by the Golgi apparatus or endo-
plasmic reticulum, was also confirmed by a dramatically
enhanced signal from the zinc fluorophore Rhodzin-3 through-
out the cytoplasm of Caco-2 cells overexpressing ZnT5B at the
plasmamembrane when compared with control cells. Our find-
ings demonstrate clearly that, in addition to mediating zinc
efflux, ZnT5B at the plasmamembrane can function to increase
cytoplasmic zinc concentration, thus indicating a need to re-
evaluate the current paradigm that SLC30 family zinc transport-
ers operate exclusively to decrease cytosolic zinc concentration.
Zinc is essential to a wide range of cellular processes through
functions that include playing a critical structural role in many
proteins, including approximately 1,000 human zinc finger
transcription factors, and also acting as a catalytic component
in several hundred human enzymes (1). Cell zinc status must
be, therefore, tightly regulated.
Membrane transporters that mediate cellular zinc uptake
and efflux as well as intracellular zinc sequestration play a
central role in cellular zinc homeostasis, but functional char-
acterization of many of these transport proteins remains
poor. Cloned mammalian cDNAs that encode proteins with
either demonstrated or assumed zinc transport activity fall
into one of two main families, classified as SLC30 and SLC39
(2, 3). SLC30 family zinc transporters (ZnT transporters in
mammalian systems) have been shown to reduce cytosolic
zinc concentration by promoting zinc efflux from the cell or
transport into intracellular compartments (3). SLC39 family
transporters have been shown to function to increase cyto-
solic zinc concentration, transporting extracellular zinc into
the cell across the plasma membrane or intracellular zinc
into the cytosol from intracellular compartments (2).
Researchers have studied the functional properties of zinc
transporters belonging to both families through a number of
different methodologies that can be divided broadly into two
main approaches: (i) direct measurement of transport func-
tion and (ii) determination of the effects of transporter
expression on cellular responses to zinc (i.e. indirect
measurement).
Most evidence relating to the function of mammalian SLC30
family transporters is indirect. For example, expression of
ZnT1 or ZnT2 rescued a mutant baby hamster kidney cell line
from zinc sensitivity (4, 5). Also, ZnT3 knock-outmice failed to
accumulate zinc in synaptic vesicles of neurons on which the
ZnT3 protein is normally expressed (6), and transformation of
ZnT4 into amutant zinc-sensitive yeast strain complemented a
mutation in ZRC1, a gene homologous to the mammalian
SLC30 family transporters (7).
Direct evidence for zinc transport functionwithin the SLC30
family includes increased zinc efflux and uptake in baby ham-
ster kidney cells expressing ZnT1 (5), 65Zn uptake into Golgi-
enriched vesicles fromHela cells transfectedwithZnT5 (8), and
65Zn uptake across the plasma membrane of Xenopus laevis
oocytes expressing ZnT5 (9). These apparently different
reported functional activities of ZnT5 may correspond with
two splice variants of the SLC30A5 gene. The sequences
reported (8, 9) differ at their N- and C-terminal regions, corre-
sponding with the use of different 5 and 3 exons (10). The
ZnT5 splice variants adopted different subcellular localizations
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when expressed as fusions to GFP2 from the corresponding
transgenes introduced into Chinese hamster ovary cells. Vari-
ant A was expressed in the Golgi apparatus, and variant B
(ZnT5B) was expressed throughout the cell, including at the
plasma membrane (10). Plasma membrane localization of
ZnT5B, specifically localization at the apical membrane, was
also observed in human intestinal Caco-2 cells (9), and we also
reported previously localization of ZnT5 to the apical enterocyte
membrane in human small intestine, using an antibody that may
potentially recognize both splice variants (11).
The aim of the present study was to examine in more detail
the functional properties of ZnT5B, the isoform expressed at the
plasma membrane. We present additional data confirming our
earlier observations that ZnT5B expressed in X. laevis oocytes
functions to increase zinc uptake (9) but also show function in
the opposite direction in the same system. In addition, we show
increased zinc-responsive reporter gene expression in Caco-2
cells in which ZnT5B was overexpressed, indicative of
increased zinc uptake across the plasma membrane. We also
show increased intracellular zinc content in cells overexpress-
ing ZnT5B and demonstrate that these effects of ZnT5B are not
related to increased accumulation of zinc in theGolgi apparatus
or endoplasmic reticulum. The observations bring into ques-
tion the prevailing view that SLC30 family transporters operate
exclusively to reduce cytosolic zinc and demonstrate clearly a
role for ZnT5B in cellular zinc uptake.
EXPERIMENTAL PROCEDURES
Plasmid Constructs—Plasmid pCR2.1-ZnT5B, for in vitro
transcription of ZnT5B, was generated as described previously
(10). Plasmid pCDNA3.1-ZnT5B-myc, for in vitro transcrip-
tion of ZnT5B with a C-terminal myc epitope tag, was gen-
erated by subcloning the ZnT5 insert obtained by restriction
digestion of pCR2.1-ZnT5B with EcoRI into the plasmid
pCDNA3.1/myc-HisA (Invitrogen). Plasmid pEGFP-ZnT5B,
for expression of ZnT5B as an N-terminal fusion to GFP in
Caco-2 cells, was generated as described previously (10). Plas-
mid pCDNA3.1-ZnT5B, for expression of ZnT5B in Caco-2
cells, was generated by restriction digestion of pEGFP-ZnT5B
with ApaI and XhoI followed by ligation into the plasmid
pCDNA3.1/Zeo (Invitrogen). The plasmid pBlue-MT2a,
including the Escherichia coli -galactosidase reporter gene
downstream of the human MT2a promoter (from 358 to
40), was generated as described previously (12).
In Vitro Transcription of ZnT5B RNA—Plasmids pCR2.1-
ZnT5B and pCDNA3.1-ZnT5-myc were linearized 3 of the
ZnT5 insert using the restriction endonuclease SstI. RNA was
transcribed from the T7 promoter upstream of the ZnT5B
cDNA using the mMessage mMachine kit (Ambion) following
the manufacturer’s instructions.
Measurement of ZnT5B Activity in X. laevis Oocytes—X. lae-
vis oocytes were prepared and injected with ZnT5B RNA or
water as described previously (9). Zinc uptake into oocytes was
measured by incubating groups of 8–10 oocytes for 30 min in
300 l of uptake buffer (100 mM NaCl, 1 mM ascorbic acid, 10
mM HEPES, pH 7.0) plus 12 M ZnCl2 including 6.4 Ci/ml
65Zn2 (PerkinElmer Life Sciences). Oocytes were washed
three times in uptake buffer before measuring 65Zn2 incorpo-
ration into single oocytes as  emission. Measurement of zinc
efflux was based on a method described previously (13). Fifty
nanoliters of 65ZnCl2 at a specific activity of 6.4 Ci/ml were
injected into the cytoplasm of individual oocytes. After a
30-min recovery period, each oocyte was transferred into a sep-
arate vial containing 0.5 ml of modified Barth’s medium (9).
The efflux of radioactive 65Zn was allowed to continue for 20
min, after which time the buffer was transferred to a counting
vial for measurement of  emission, and 0.5 ml of fresh buffer
were added. This process was repeated for 100 min. The
amount of radioactivity that remained in each oocyte was also
determined. Tracer efflux was assessed from plots of ln(Ct/
C0) against time, whereC0 andCt are the levels of activity (dpm)
in the cell at the start and end, respectively, of each experimen-
tal period (obtained by summation of residual oocyte radioac-
tivity and sequential radioactive losses to vials by tracer efflux).
Localization of ZnT5B in X. laevis Oocyte—Oocytes injected
with RNA transcribed in vitro from plasmid pCDNA3.1-
ZnT5B-myc were fixed at 4 °C for 1 h in 4% (w/v) paraformal-
dehyde, prepared in PBS. After washing in PBS, oocytes were
incubated at 4 °C in a 30% sucrose solution overnight. Oocytes
were frozen rapidly in OCTmedium (VWR International), and
sections were cut to a thickness of 15 m using a Shandon
Cryotome. Sections were mounted on slides and incubated for
20min in 200 l of blocking solution (PBS containing 10% fetal
calf serum). The blocking solution was removed, and the slides
were incubated in the dark for 1 h with 100 l of PBS, 10% fetal
calf serum containing FITC-conjugated anti-myc antibody
(Invitrogen; 1:500 dilution of antibody). After incubation, slides
were washed twice in PBS. Sections were then mounted in
Vectashield mounting medium (Vector Laboratories Ltd.), and
the pattern of fluorescence was visualized by fluorescence
microscopy (Leica DMBRE).
Transfection of Caco-2 Cells and Measurement of Reporter
Gene Activity—Human intestinal Caco-2 cells were cultured
routinely as described previously (9). For transfection, Caco-2
cells were seeded into 12-well plates at 3.5  105 cells/well.
Cells were transfected 24 h after seeding using Genejammer
reagent (Stratagene) following the manufacturer’s instructions
and using a ratio of DNA:transfection reagent of 2 g:4.5 l.
After 24 h, transfected cells were incubated in serum-free
medium, with or without the addition of 100 M ZnCl2 or 100
M CuSO4 plus 1 mM ascorbate, for a further 24 h. -Galacto-
sidase activity was measured in cell lysates using the substrate
chlorophenol red--D galactopyranoside (Sigma), as described
previously (12). Protein concentration was determined using
the Bradford assay (Bio-Rad Laboratories) with bovine serum
albumin (Sigma), as the standard.
Visualization of Intracellular Zinc Concentration Using
Rhodzin-3—Caco-2 cells were seeded at a density of 5  105
cm2 onto glass coverslips. Twenty-four hours after seeding,
cells were transfected with pEGFP-ZnT5B or vector only
(pEGFPN; Clontech). After a further 24 h, cells were loaded
with the zinc fluorophore Rhodzin-3 AM (5M; Invitrogen) for
2 The abbreviations used are: GFP, green fluorescent protein; ZnT5B, ZnT5
variant B; PBS, phosphate-buffered saline; MT2a, metallothionein 2a; FITC,
fluorescein isothiocyanate.
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30 min at room temperature. Cells were washed with PBS and
left at 37 °C for 1 h to allow de-esterification. Cells were treated
with 100 M ZnCl2 in serum-free medium for a further 24 h
prior to fixing for 1 h in 4% (v/v) paraformaldehyde, prepared in
PBS. Cells weremounted inVectashieldmountingmedium (Vec-
tor Laboratories Ltd.), and the pattern of fluorescence was visual-
ized by confocal laser scanningmicroscopy (Leica TCSNT).
Data Analysis—Data are presented asmean S.E. Statistical
analysis was carried out using theMicrosoft SPSS package. Dif-
ferences were considered significant at p  0.05.
RESULTS
We assayed directly the functional activity of ZnT5B by
measuring the flux of the radiotracer 65Zn2 across the plasma
membrane of X. laevis oocytes injected with ZnT5B RNA. The
uptake of 65Zn2, supplied at 12 M, into oocytes injected with
ZnT5B cRNA was significantly greater (4-fold) than into
uninjected controls (Fig. 1A). For measurement of zinc efflux,
oocytes were injected with 50 nl (5 Ci/l) of 65ZnCl2. The
efflux of 65Zn2 was increased in oocytes injected with ZnT5B
RNA when compared with water-injected controls (Fig. 1B).
The rate constant for zinc efflux in this experiment was calcu-
lated as the slope of progressive tracer loss (ln (Ct/co)) with time
and was 2.45  0.4 ( 10 3)/min for ZnT5-injected oocytes
and 1.15  0.2 ( 103)/min for controls (n  8 cells each, p 
0.0001 by one way analysis of variance followed by Dunnett’s
multiple comparisons test). Increasing the extracellular Zn2
concentration to 1 mM had no effect on 65Zn2 efflux (Fig. 1B),
indicating that ZnT5B canmediate zinc efflux against a concen-
tration gradient. To establish the location of the heterologously
expressed ZnT5B inX. laevis oocytes, cells were injected with a
C-terminal myc-tagged ZnT5B construct, and the protein was
detected in sections of paraformaldehyde-fixed oocytes using a
FITC-labeled anti-myc antibody. Immunofluorescence at the
plasma membrane in oocytes injected with ZnT5B-myc cRNA
was observed and was clearly not visible in water-injected
controls (Fig. 1C), demonstrating localization at the plasma
membrane.
To determine the effect of increased ZnT5 expression on
intracellular zinc concentration in a physiologically relevant
cell type, we measured the effect of heterologous overexpres-
sion of ZnT5B, in the vector pCDNA3.1, on the activity of a
zinc-activated reporter gene, comprising the E. coli -galacto-
sidase coding sequence downstream of the zinc-activated
humanMT2a promoter. Co-expression of ZnT5 (from plasmid
pCDNA3.1-ZnT5B) with the reporter construct (plasmid
pBlue-MT2a) increased significantly -galactosidase activity
(4-fold) in serum-freemediumwith and without the addition
of 100 M extracellular zinc when compared with cells
co-transfected with pBlue-MT2a plus vector pCDNA3.1 only
(no ZnT5 insert), indicating increased transcription from the
zinc-responsive MT2a promoter and so increased intracellular
zinc concentration (Fig. 2A). To exclude the possibility that the
effect of ZnT5B overexpression on MT2A promoter activity
was the result of any change in intracellular Cu2 concentra-
tion or distribution, we demonstrated that the reporter gene
activity was unaffected by changes in Cu2 availability in this
experimental system (Fig. 2B).
We determined the effects of ZnT5B overexpression, as an
N-terminal fusion to GFP to allow visualization, on intracellu-
lar zinc concentration and distribution inCaco-2 cells using the
FIGURE 1. ZnT5B-mediated transmembrane zinc flux in X. laevis oocytes.
A shows that uptake of 65Zn2 over 30 min from a solution containing 12 M
ZnCl2 by oocytes expressing ZnT5B (transcribed in vitro from plasmid pCR2.1-
ZnT5B) or by uninjected controls, as indicated. Data are expressed as mean  S.E.
for n  8–10 oocytes. ***, p  0.001 by Student’s t test. B shows the efflux of
65Zn2 with time from oocytes injected with ZnT5B cRNA (filled symbols) when
compared with water-injected controls (open symbols). Fifty nanoliters of ZnCl2 at
a specific activity of 5 Ci/l was injected into each oocyte, and efflux was fol-
lowed over 100 min. Efflux in the presence of 1 mM ZnCl2 (between 40 and 60
min) is indicated. C0 and Ct are the levels of activity (dpm) in the cell at the start
and end, respectively, of each experimental period (obtained by summation of
residual oocyte radioactivity and sequential radioactive losses to vials by tracer
efflux). Data are expressed as mean  S.E. for n  8–10. C, panel i, shows repre-
sentative images of three oocytes injected with ZnT5B cDNA tagged at the C
terminus with the myc epitope (transcribed in vitro from plasmid
pCDNA3.1-ZnT5B-myc) and probed with FITC-conjugated anti-myc antibody
(green) viewed using the 200 objective lens. Specific anti-myc immunofluores-
cence is clearly visible. C, panel ii, shows representative images of three control
(water-injected) oocytes probed with FITC-conjugated anti-myc antibody
viewed using the 200 objective lens. Anti-myc specific staining is absent in
these controls. Arrows point to the plasma membrane in each case.
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zinc-activated fluorophore Rhodzin-3 (Invitrogen). Cells
expressing ZnT5B as an N-terminal fusion to GFP (from plas-
mid pEGFP-ZnT5B) showed localization of ZnT5B to the
plasmamembrane alongwith clear cytoplasmic red/orange flu-
orescence, which was not visualized in cells transfected with
vector pEGFPN only (Fig. 3), indicating dramatically elevated
total intracellular zinc concentration in cells expressing ZnT5B
at the plasma membrane.
DISCUSSION
It is becoming widely accepted that members of the SLC30
family ofmammalian zinc transporters function to reduce cyto-
solic zinc concentration by promoting zinc efflux from the cell
or intracellular zinc sequestration. The results of the current
study and evidence from previous work (9) indicate clearly that
this dogma should be challenged. Specifically, ZnT5B can
mediate zinc uptake across the plasma membrane.
Expression of ZnT5B at the plasma membrane in X. laevis
oocytes resulted in increased transmembrane fluxes of 65Zn2,
consistent with the view that ZnT5B mediates zinc transport
across the plasma membrane. Previously, we demonstrated
that ZnT5B mediates Zn2 uptake in the X. laevis oocyte (9).
We now provide further confirmation of these observations
using a modified uptake buffer in which ZnT5B-mediated zinc
uptake at an extracellular concentration of 12 M was greater
when compared with control (4-fold higher) than was meas-
ured previously (2-fold higher). We also now demonstrate
that ZnT5B is expressed at the plasma membrane in X. laevis
oocytes. In addition, we demonstrate the efflux of Zn2 in the
same expression system. Based on these observations, we sug-
gest that ZnT5B is capable of bidirectional Zn2 transport. A
possible explanation for increased Zn2 flux in a specific direc-
tion (uptake or efflux) in oocytes expressing ZnT5B is that it is
a compensatory response to ZnT5B-mediated zinc transport in
the opposite direction. Such a mechanism was suggested to
explain the increase in zinc uptake as well as efflux into baby
hamster kidney cells expressing ZnT1 (5). We demonstrated
previously that the possibility that zinc uptake into oocytes
expressing ZnT5B is compensatory for zinc efflux can be
excluded by virtue of a differential effect of extracellular pH on
the ZnT5B-mediated and endogenous oocyte zinc uptake
mechanisms (9). The possibility that efflux was a compensatory
response to zinc uptake can be excluded on the grounds that
ZnT5B-stimulated efflux occurred in the absence of extracellu-
lar zinc. A major exchange mode of ZnT5B function can be
excluded because 65Zn2 effluxes were not trans-stimulated in
the presence of extracellular zinc. Bidirectional transporter-
mediated transport of zinc is not without precedent and was
reported in Saccharomyces cerevisiae for the transporter Yke4p,
a member of the SLC39 family (14).
Tomeasure ZnT5B function in a physiologically relevant cell
type, the effect of increased ZnT5B expression on the intracel-
lular zinc status of the human intestinal cell line Caco-2 was
determined by measuring the activity of a zinc-stimulated
reporter gene. Increased activity of the zinc-responsive MT2a
promoter when ZnT5B was co-expressed in Caco-2 cells indi-
cated increased total intracellular zinc content, altered intracel-
lular zinc partitioning or altered status, or intracellular distri-
bution with respect to other metals capable of activating MT
expression. It is known that copper can activate metallothion-
ein gene expression (15), but an effect on copper status and/or
distribution as being responsible for the observed activation of
the MT2a promoter can be excluded because extracellular
Cu2 did not induce an MT2a promoter response in this sys-
tem. An increase in total intracellular zinc mediated by ZnT5B
FIGURE 2. The effect of ZnT5B expression on the activity of the zinc-acti-
vated MT2a promoter. Data are -galactosidase activity in lysates from
Caco-2 cells co-transfected transiently with an MT2a-promoter--galactosid-
ase-reporter construct (pBlue-MT2a) plus ZnT5B (pCDNA3.1-ZnT5B) or corre-
sponding vector only (pCDNA3.1), as indicated (A), or transfected with pBlue-
MT2a only (B), and maintained for 24 h in serum-free medium with or without
the addition of 100 M ZnCl2 (A and B) or 100 M CuSO4 plus 1 mM ascorbate
(B), as indicated. The inset graph in A shows the measurements made in
serum-free medium plotted on an expanded scale, for clarity. Data are
expressed as mean  S.E. for n  3– 6. ***, p  0.001 by one-way analysis of
variance followed by Bonferroni’s multiple comparisons test.
FIGURE 3. Visualization of increased cellular zinc content in cells overex-
pressing ZnT5B. Caco-2 cells were transfected with ZnT5 expressed as an
N-terminal fusion to GFP (pEGFP-ZnT5B (A)) or with vector only (pEGFPN (B)).
Twenty-four hours after transfection, cells were loaded with the zinc fluoro-
phore Rhodzin-3 prior to treatment with 100 M ZnCl2 for 24 h. Cells were
then fixed in 4% paraformaldehyde. GFP (shown in green) and Rhodzin-3
(shown in red) were detected by confocal laser-scanning microscopy.
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expression at the plasmamembrane, in the absence of effects on
intracellular zinc sequestration, was confirmed by a greatly
increased signal from the zinc fluorophore Rhodzin-3 through-
out the cytoplasm in Caco-2 cells expressing a GFP-tagged
ZnT5B transgene. There was no evidence of zinc accumulation
in the Golgi apparatus, where localization of ZnT5 splice vari-
ant A (8, 10), as well as of ZnT6 (16) and ZnT7 (17), has been
reported, or in the endoplasmic reticulum. It has been reported
that Rhodzin-3 is a marker of mitochondrial zinc content (18),
so it is feasible that the pattern of localization we observed
included a component due to increased total cytoplasmic zinc
concentration resulting in uptake into mitochondria.
The evident bidirectional transport capability of ZnT5B
raises questions about the physiological role of this transporter.
We demonstrated previously apical location of ZnT5B in
Caco-2 cells (9) and detected ZnT5 at the apical membrane in
human small intestine (11). An apically located intestinal zinc
transporter operating in an uptake mode would facilitate the
absorption of dietary zinc. Our previous observation that
expression of ZnT5 was reduced in the small intestinal mucosa
of human volunteers given a zinc supplement for 14 days (11)
can be rationalized in terms of this being a homeostatic
response to reduce the uptake of excess zinc by the transporter
operating in uptake mode. An apical intestinal zinc transporter
operating in efflux mode may regulate net zinc absorption to
maintain homeostasis at high dietary intakes, but our data on
the regulatory response of the transporter to increased zinc
intake (11) appear inconsistent with such a role for ZnT5B in
the intestine.
In summary, the data presented demonstrate that ZnT5 can
operate in an effluxmode, in agreementwith the accepted func-
tional characteristics of zinc transporters belonging to the
SLC30 family, but also has the capability to increase intracellu-
lar zinc content in the absence of any effect on zinc sequestra-
tion into specific intracellular compartments. The findings,
therefore, necessitate re-evaluation of the current paradigm
that SLC30 family zinc transporters operate exclusively to
decrease cytosolic zinc concentration.
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